Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03323502 · ClinicalTrials.gov registry record · NA
Aligning Patient Preferences: a Role Offering Alzheimer's Patients, Caregivers, and Healthcare Providers Education and Support
A NA study of Alzheimer Disease and Dementia, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 47,396
- Enrollment target
- 2
- Study locations
NCT03323502: Completed NA study of Alzheimer Disease and Dementia, sponsored by Indiana University.
NCT03323502 is a NA study of Alzheimer Disease and Dementia that has completed, run by Indiana University. The registered enrollment target is 47,396 participants, above the 2,596-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (1726% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03323502, a NA study of Alzheimer Disease and Dementia, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 47,396 participants
- Enrollment target
- 2
- Study locations
Study Summary
Nursing home (NH) patients with Alzheimer's disease and related dementias often receive unwanted, burdensome treatments such as hospitalization. Advance care planning (ACP) is a key strategy to support patients and family-caregivers in making informed decisions and ensuring treatment preferences are proactively known and honored. The ACP Specialist Program will improve care and reduce unwanted, burdensome hospitalizations through improved ACP procedures, standardized staff education on ACP, and systematic ACP facilitation delivered by existing NH staff.
Primary Outcome
Hospital transfers (admissions and emergency department visits) over 12 months between Alzheimer's Disease and Related Dementias (ADRD) patients in intervention vs. control NHs
Conditions Studied
Interventions
- OTHER Standard of care
- BEHAVIORAL APPROACHES ACP Specialist Program
Study Locations (2)
Indiana
- Miller's Merry Manor - Warsaw
Kentucky
- Signature HealthCARE LLC - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47,396 participants |
| Start Date | 2020-02-01 |
| Est. Completion | 2022-08-31 |
| Phase | NA |
What the finished NCT03323502 record still lists
NCT03323502 is an interventional study that assigns participants to a tested intervention. Its 47,396 participants enrollment target places it among the larger protocols in the corpus, above the 2,596-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (1726% higher).
The record links to 2 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 2 interventions - of which Standard of care is the first listed.
NCT03323502 reports a single indexed study location in Indiana, Kentucky.
Frequently Asked Questions
What is clinical trial NCT03323502 about?
NCT03323502 is a clinical study titled "Aligning Patient Preferences: a Role Offering Alzheimer's Patients, Caregivers, and Healthcare Providers Education and Support". Nursing home (NH) patients with Alzheimer's disease and related dementias often receive unwanted, burdensome treatments such as hospitalization. Advance care planning (ACP) is a key strategy to support patients and family-caregivers in making informed decisions and ensuring treatment preferences are...
What is the current status of trial NCT03323502?
This trial is currently completed. It is a NA study. The enrollment target is 47,396 participants. The study started on 2020-02-01. Estimated completion is 2022-08-31.
What conditions does trial NCT03323502 study?
This clinical trial studies the following conditions: Alzheimer Disease, Dementia.
What interventions are being tested in trial NCT03323502?
The interventions under investigation include: Standard of care (OTHER), APPROACHES ACP Specialist Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT03323502?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03323502 being conducted?
This trial has 2 study locations across Indiana, Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimer Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03323502's enrollment target sits among peer trials
47,396 3rd of 306 higher than 304 of 306 other Alzheimer Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alzheimer Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms
RECRUITING · NA
-
Brain Outcomes With Lifestyle Change in Down Syndrome
RECRUITING · NA
-
Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease
RECRUITING · NA
-
A Feasiblity Study of Green Activity Program for People Living With Memory Challenges
RECRUITING · NA
-
Connect-Home: Alzheimer's Disease and Related Dementias
RECRUITING · NA
-
Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03977402 · 47,500 participants
Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
- NCT06655974 · 48,000 participants · NA
Predictive Modeling for Social Needs in Emergency Department Settings
- NCT06597968 · 45,991 participants
Evaluating the Real World Performance of an AI Based Lung Nodule Detection Tool
- NCT06824350 · 45,450 participants · NA
Clean Trial - Chlorination to Reduce Enteric and Antibiotic Resistant Infections in Neonates
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI